Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy-Reference-Cited by-同舟云学术

Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy

Published:2021-01-01 Issue:1 Volume:28 Page:1389-1396
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Chen Jianhua¹,Ning Eerdunbagena²,Wang Zhijun³⁴,Jing Ziqi¹,Wei Guijie¹,Wang Xue¹,Ma Pengkai¹

Affiliation:

1. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China

2. Haikou People’s Hospital, Hainan, China

3. Division of interventional radiology, Department of Geriatric Medicine &National Clinical Research Center of Geriatric Disease, The 2nd Medical Center of Chinese PLA General Hospital, Beijing, China

4. Department of interventional radiology, The 1st & 5th Medical Center of Chinese PLA General Hospital, Beijing, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2021.1945167

Reference22 articles.

1. Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases

2. The influence of shape and charge on protein corona composition in common gold nanostructures

3. Molecular weight-dependent degradation and drug release of surface-eroding poly(ethylene carbonate)

4. Dose intensity and toxicity associated with Taxotere formulation

5. A lyophilized sterically stabilized liposome-containing docetaxel: in vitro and in vivo evaluation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges;International Journal of Biological Macromolecules;2024-10

2. Advancements in nanoengineered paclitaxel formulations: A comprehensive review of blood-brain barrier infiltration strategies for glioblastoma therapy;Biomedical Engineering Advances;2024-06

3. In vivo safety evaluation method for nanomaterials for cancer therapy;Clinical and Translational Oncology;2024-04-04

4. CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination;Journal of Nanobiotechnology;2024-01-19

5. Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience;Cancer Medicine;2023-12